Orna Therapeutics Holdings, LLC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-23. The offering totals $300.0M, of which $120.6M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Daniel M Anderson | Director | Cambridge, MA |
| Sakae M Asanuma | Director | Cambridge, MA |
| Thomas M Barnes | Director | Cambridge, MA |
| Thomas M Ebeling | Director | Cambridge, MA |
| Ansbert M Gadicke | Director | Cambridge, MA |
| Brian M Goodman | Director | Cambridge, MA |
| Morana M Jovan-Embiricos | Director | Cambridge, MA |
| Francesco M Marincola | Director | Cambridge, MA |
| Thomas M Barnes | Executive Officer | Cambridge, MA |
| Nishla M Keiser | Executive Officer | Cambridge, MA |
| Robert M Marby | Executive Officer | Cambridge, MA |
| John M McCabe | Executive Officer | Cambridge, MA |
| William M Shen | Executive Officer | Cambridge, MA |